• Je něco špatně v tomto záznamu ?

Encapsulation of poorly soluble drugs in yeast glucan particles by spray drying improves dispersion and dissolution properties

G. Ruphuy, I. Saloň, J. Tomas, P. Šalamúnová, J. Hanuš, F. Štěpánek,

. 2020 ; 576 (-) : 118990. [pub] 20191230

Jazyk angličtina Země Nizozemsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc20028478

Grantová podpora
NV16-27522A MZ0 CEP - Centrální evidence projektů

In this work, novel amorphous solid dispersions based on yeast glucan particles were produced. Yeast glucan particles are hollow and porous, and they are mainly composed of amorphous polysaccharides. We hypothesized that these particles are suitable candidates for the amorphization of drugs with low water solubility. Model drugs ibuprofen and curcumin were successfully encapsulated in glucan particles by spray drying. Different spray-drying parameters were tested to evaluate the influence of atomizing droplet size and initial solid content on encapsulation efficiency. It was shown that higher solid content and, more significantly, larger droplet sizes lead to higher encapsulation efficiencies. The encapsulation efficiency of ibuprofen (10 wt%) into glucan particles was considerably improved from 41.3 ± 0.5% to 64.3 ± 0.2% by increasing initial solid content and droplet size with the two-fluid nozzle. The spray drying process was further optimized by using the ultrasonic nozzle and it was possible to achieve complete encapsulation of ibuprofen and curcumin without any precipitation of the active compound outside of the glucan particles. Overall, it was possible to produce completely amorphous composites with outstanding wettability and dispersion properties, and with significantly faster dissolution rates when compared to the micronized crude drug.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc20028478
003      
CZ-PrNML
005      
20210114154008.0
007      
ta
008      
210105s2020 ne f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.ijpharm.2019.118990 $2 doi
035    __
$a (PubMed)31899318
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Ruphuy, Gabriela $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic. Electronic address: ruphuycg@vscht.cz.
245    10
$a Encapsulation of poorly soluble drugs in yeast glucan particles by spray drying improves dispersion and dissolution properties / $c G. Ruphuy, I. Saloň, J. Tomas, P. Šalamúnová, J. Hanuš, F. Štěpánek,
520    9_
$a In this work, novel amorphous solid dispersions based on yeast glucan particles were produced. Yeast glucan particles are hollow and porous, and they are mainly composed of amorphous polysaccharides. We hypothesized that these particles are suitable candidates for the amorphization of drugs with low water solubility. Model drugs ibuprofen and curcumin were successfully encapsulated in glucan particles by spray drying. Different spray-drying parameters were tested to evaluate the influence of atomizing droplet size and initial solid content on encapsulation efficiency. It was shown that higher solid content and, more significantly, larger droplet sizes lead to higher encapsulation efficiencies. The encapsulation efficiency of ibuprofen (10 wt%) into glucan particles was considerably improved from 41.3 ± 0.5% to 64.3 ± 0.2% by increasing initial solid content and droplet size with the two-fluid nozzle. The spray drying process was further optimized by using the ultrasonic nozzle and it was possible to achieve complete encapsulation of ibuprofen and curcumin without any precipitation of the active compound outside of the glucan particles. Overall, it was possible to produce completely amorphous composites with outstanding wettability and dispersion properties, and with significantly faster dissolution rates when compared to the micronized crude drug.
650    _2
$a aerosoly $7 D000336
650    _2
$a kurkumin $x chemie $7 D003474
650    12
$a vysoušení $7 D003890
650    12
$a nosiče léků $7 D004337
650    _2
$a příprava léků $7 D004339
650    _2
$a uvolňování léčiv $7 D065546
650    _2
$a ibuprofen $x chemie $7 D007052
650    _2
$a kinetika $7 D007700
650    _2
$a velikost částic $7 D010316
650    _2
$a Saccharomyces cerevisiae $x chemie $7 D012441
650    _2
$a rozpustnost $7 D012995
650    12
$a ultrazvuk $7 D014465
650    _2
$a beta-glukany $x chemie $x izolace a purifikace $7 D047071
655    _2
$a časopisecké články $7 D016428
700    1_
$a Saloň, Ivan $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
700    1_
$a Tomas, Jan $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
700    1_
$a Šalamúnová, Petra $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
700    1_
$a Hanuš, Jaroslav $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
700    1_
$a Štěpánek, František $u Department of Chemical Engineering, University of Chemistry and Technology Prague, Technická 3, 166 28 Prague 6, Czech Republic.
773    0_
$w MED00002359 $t International journal of pharmaceutics $x 1873-3476 $g Roč. 576, č. - (2020), s. 118990
856    41
$u https://pubmed.ncbi.nlm.nih.gov/31899318 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20210105 $b ABA008
991    __
$a 20210114154005 $b ABA008
999    __
$a ok $b bmc $g 1608813 $s 1119658
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2020 $b 576 $c - $d 118990 $e 20191230 $i 1873-3476 $m International journal of pharmaceutics $n Int. j. pharm. $x MED00002359
GRA    __
$a NV16-27522A $p MZ0
LZP    __
$a Pubmed-20210105

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...